News | November 25, 2021
Bharat Biotech updates on the Lancet study on Covaxin efficacy
An effectiveness result of 50 per cent achieved during the peak delta variant Covid-19 wave in India, in a highrisk study population of physicians and healthcare workers, in a hospital environment, provides insights into the efficacy and effectiveness of Covaxin
_256_275.jpg)